Skip to content

A clinical trial to compare the effects of 3 drugs - Dexmeditomedine, Ketamine and Preservative free lignocaine in reducing the pain caused by injection of propofol

"Comparison of intravenous pretreatment with dexmeditomedine, ketamine and preservative free lignocaine in alleviating propofol injection pain -- A prospective randomized study." - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060528
Enrollment
150
Registered
2023-12-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: PROPOFOL: 25% of the calculated dosage of propofol will be administered to the patient over a period of 60 seconds before induction of anaesthesia Control Intervention1: DEXMEDITOMEDINE

Sponsors

Dr Sanju Ashokkumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who are willing to participate in the study 2. Patients undergoing surgeries that require general anaesthesia with propofol as induction agent 3. Age group of 18-60 of either sex 4. American society of anaesthesiologist (ASA) physical status I and II

Exclusion criteria

Exclusion criteria: 1.History of drug allergy 2.Patients who dont fit in the age/ ASA criteria 3.History of psychiatric disorder 4.History of seizure disorder 5.History of substance abuse

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of intravenous dexmeditomedine ,ketamine and preservative free lignocaine in reducing the Intensity of pain upon injection of propofol graded on a four point scale (0-3) None (0) - No response to questioning Mild (1) - Pain reporting in response to questioning only Moderate (2) - Pain reporting in response to questioning and or pain reported spontaneously without questioning Severe (3) - Strong vocal response accompanied by facial grimace, arm withdrawals or tearsTimepoint: 0 seconds, 30 seconds and 60 seconds

Secondary

MeasureTime frame
The hemodynamic variability in patients upon injecting these study agents.Timepoint: 0 seconds and 1 minute

Countries

India

Contacts

Public ContactDr Shivanandha PT

Shimoga Institute of Medical Sciences

shivananda1233@gmail.com9986327599

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026